Daily News Podcast

Valsartan cancer risk is low

Publish date: July 31, 2018

 

The FDA says that cancer risk associated with NDMA contained in impure valsartan is definitely real, but it is very low. Also today, drinking during pregnancy could impact cognition, sexual function counseling should start early, and those with HIV develop more frailty. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Telemedicine payment expansion?
MDedge Psychiatry
Bundle pay plan didn’t save money
MDedge Psychiatry
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Psychiatry
Is fish oil’s heart benefit a fish tale?
MDedge Psychiatry
Charles L. Raison: Ketamine and PTSD
MDedge Psychiatry
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
MDedge Psychiatry
Blood pressure meds cut cognitive impairment risk
MDedge Psychiatry
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Psychiatry
AAP: Fertility, sexual function counseling should start early
MDedge Psychiatry
Free skin cancer screening highlights need
MDedge Psychiatry